Canaan Partners β 2021 Investments
8 investments dated 2021 Β· listed companies and verified rows first Β· show all
BiotechMorrisville, US
Damian deGoa(Executive Officer, Director)Michael Kaseta(Executive Officer)
BoardPaul B. Manning(Director)Joanna Horobin(Director)Raman Singh(Director)
Board seatStephen BlochΒ· per SEC Form D
Co-investorsNew Enterprise Associates (NEA)PBM Capital
HealthtechWalnut Creek, US
Lester John Lloyd(Previously CEO, now Chairman & Director.)Andrew Thomas Lloyd(General Counsel, Corp Sec'y)Ken Traverso(CEO, Director)Donald Shirley(President, Director)Timothy Patrick Lloyd(CTO, Director)
Board seatWende HuttonΒ· per SEC Form D Β· filed Nov 2021
Day One is a biopharmaceutical company that develops first- or best-in-class targeted medicines for children and adults with life-threatening diseases, with a focus on cancers such as pediatric brain tumors.
BiotechHealthtechSouth San Francisco, US
Jeremy Bender(Executive Officer, Director)
BoardMichael Gladstone(Director)inDerek DiRocco(Director)inJulie Papanek Grant(Director)inJohn Josey(Director)Daniel Becker(Director)
Board seatJulie GrantΒ· per SEC Form D
Co-investorsAccess BiotechnologyAtlas VentureRA CapitalThe Column Group
Glooko operates a cloud-connected diabetes management platform that automatically syncs data from CGMs and insulin pumps into care teams' clinical workflows for in-office and remote patient monitoring.
Digital HealthHealthtechSaaSPalo Alto, US
Clay Davidson(Executive Officer)inPrakash Menon(Executive Officer)inEd Marshall(Executive Officer)David Pass(Executive Officer)Adam Hameed(Executive Officer)Mark Beucler(Executive Officer)in
Board seatWende HuttonΒ· per SEC Form D
Co-investorsHealth Catalyst CapitalSamsung Next
JOOR is a digital wholesale platform connecting brands and retailers globally for buying and selling fashion products.
B2B MarketplacesE-commerceRetail TechSaaSNew York, US
Kristin Savilia(Executive Officer, Director)
BoardDan Ciporin(Director)Michael Brown(Director)inEd Neumann(Director)
Board seatMaha IbrahimΒ· per SEC Form D
Co-investorsAkkadian VenturesBattery VenturesEastward Capital PartnersGreat Oaks Venture CapitalMultiplier CapitalRed Sea Ventures
Alterome develops targeted, genomically-defined cancer therapies aimed at aggressive cancers that lack effective treatment options, focusing on more precise drugs with fewer off-target effects.
BiotechHealthtechMedical DevicesSan Diego, US
Eric A. Murphy(Executive Officer, Director, Promoter)Ryan B. Corcoran(Director, Promoter)
BoardThilo Schroeder(Director)inCarl Gordon(Director)inArjun Goyal(Director)in
Co-investorsNextech InvestOrbiMedVida VenturesDigitalis VenturesNVIDIA
Azibo is a property management platform that enables landlords to collect rent, screen tenants, manage leases, track maintenance, and handle accounting and tax preparation.
FintechPropTechSaaSReno, US
Christopher Hsu(Executive Officer, Director)
BoardDavid Weiden(Director)inGregor Watson(Director)Richard Boyle(Director)inSarah Dickens Spoja(Director)
Co-investorsCamber CreekRET VenturesContext VenturesGaingelsKhosla VenturesQED Investors
Marvin provides mental health and well-being support for healthcare employees, combining input from therapists, academic researchers, data scientists, and clinical operations leaders.
AI & Machine LearningDigital HealthHealthtechMental HealthSan Marino, US
John Bracaglia(Executive Officer, Director)
Co-investorsCanvas VenturesDesigner FundCanaryLiquid VenturesVillage Global
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.